Stock analysis for Protagonist Therapeutics Inc (PTGX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Key Stock Data · P/E Ratio (TTM). (08/21/24) · EPS (TTM). $ · Market Cap. $ B · Shares Outstanding. M · Public Float. M · Yield. PTGX. Key Stock Data · P/E Ratio (TTM). (08/21/24) · EPS (TTM). $ · Market Cap. $ B · Shares Outstanding. M · Public Float. M · Yield. PTGX. Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing. Find the latest analyst research, reports, and ratings for Protagonist Therapeutics, Inc. Common Stock (PTGX) at onehead.online
Valuation: Protagonist Therapeutics, Inc. ; P/E ratio * · P/E ratio * ; EV / Sales * · EV / Sales * ; Yield * · Yield *. Protagonist Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTGX. The last closing price for Protagonist. Price, Volume. Change, % Change. Intraday High, Intraday Low. 52 Week High, 52 Week Low. Pricing delayed by 20 minutes. STOCK CHART. Contact Us. Get Protagonist Therapeutics Inc (onehead.online) real-time stock quotes, news, price and financial information from Reuters to inform your trading and. (NASDAQ: PTGX) Protagonist Therapeutics's week high was $, and its week low was $ It is currently % from its week high and % from. Protagonist Therapeutics, Inc. (PTGX) ; Aug 22, , , , , ; Aug 21, , , , , Based on 5 Wall Street analysts offering 12 month price targets for Protagonist Therapeutics in the last 3 months. The average price target is $ with a. To buy fractional shares of Protagonist Therapeutics, Inc. stock, you'll need to sign up for Stash and open a personal portfolio. Stash allows you to purchase. View the PTGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Protagonist. Get the latest Protagonist Therapeutics Inc (PTGX) real-time quote, historical performance, charts, and other financial information to help you make more. Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing.
Stock analysis for Protagonist Therapeutics Inc (PTGX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. PTGX | Complete Protagonist Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Discover real-time Protagonist Therapeutics, Inc. Common Stock (PTGX) stock prices, quotes, historical data, news, and Insights for informed trading and. Thinking of buying or selling Protagonist Therapeutics Inc stock that's listed in a currency different from your local one? Use our international stock. Protagonist Therapeutics Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $B. Ratings · Protagonist Therapeutics Is Maintained at Market Outperform by JMP Securities · Protagonist Therapeutics Price Target Cut to $/Share From $ Get Protagonist Therapeutics Inc (PTGX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The 25 analysts offering price forecasts for Protagonist Therapeutics have a median target of , with a high estimate of and a low estimate of Protagonist Therapeutics Inc. company facts, information and financial ratios from MarketWatch.
PTGX - Protagonist Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM). Welcome to Protagonist, a clinical-stage biopharmaceutical company. We strive to improve patients' lives through the power of peptide drug discovery and. Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development. Protagonist Therapeutics Inc (PTGX) USD · Add to watchlist · This stock can be held in a · Stocks and Shares ISA Lifetime ISA SIPP Fund and Share Account. In depth view into PTGX (Protagonist Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.
Cramer’s Stop Trading: Viking Therapeutics
Cd Rates Louisville Ky | Current 15 Year Mortgage Rates Utah